BIOGEN INC (IDP.DE) Stock Fundamental Analysis
FRA:IDP - Deutsche Boerse Ag - US09062X1037 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to IDP. IDP was compared to 65 industry peers in the Biotechnology industry. IDP has an excellent profitability rating, but there are some minor concerns on its financial health. IDP is valued quite cheap, but it does not seem to be growing. With these ratings, IDP could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year IDP was profitable.
In the past year IDP had a positive cash flow from operations.
Each year in the past 5 years IDP has been profitable.
IDP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 5.28%, IDP belongs to the best of the industry, outperforming 81.54% of the companies in the same industry.
IDP has a better Return On Equity (8.71%) than 81.54% of its industry peers.
IDP has a better Return On Invested Capital (9.95%) than 87.69% of its industry peers.
IDP had an Average Return On Invested Capital over the past 3 years of 10.57%. This is in line with the industry average of 12.12%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 8.71% | ||
| ROIC | 9.95% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
1.3 Margins
IDP has a Profit Margin of 15.07%. This is amongst the best in the industry. IDP outperforms 81.54% of its industry peers.
In the last couple of years the Profit Margin of IDP has declined.
The Operating Margin of IDP (26.30%) is better than 87.69% of its industry peers.
In the last couple of years the Operating Margin of IDP has declined.
The Gross Margin of IDP (75.58%) is better than 72.31% of its industry peers.
IDP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.3% | ||
| PM (TTM) | 15.07% | ||
| GM | 75.58% |
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
2. Health
2.1 Basic Checks
IDP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
IDP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IDP has been reduced compared to 5 years ago.
IDP has a better debt/assets ratio than last year.
2.2 Solvency
IDP has an Altman-Z score of 2.78. This is not the best score and indicates that IDP is in the grey zone with still only limited risk for bankruptcy at the moment.
IDP has a better Altman-Z score (2.78) than 72.31% of its industry peers.
IDP has a debt to FCF ratio of 2.74. This is a good value and a sign of high solvency as IDP would need 2.74 years to pay back of all of its debts.
IDP's Debt to FCF ratio of 2.74 is amongst the best of the industry. IDP outperforms 87.69% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that IDP is not too dependend on debt financing.
IDP has a Debt to Equity ratio of 0.27. This is comparable to the rest of the industry: IDP outperforms 53.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.74 | ||
| Altman-Z | 2.78 |
ROIC/WACC1.09
WACC9.13%
2.3 Liquidity
IDP has a Current Ratio of 1.44. This is a normal value and indicates that IDP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.44, IDP is doing worse than 64.62% of the companies in the same industry.
IDP has a Quick Ratio of 1.01. This is a normal value and indicates that IDP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.01, IDP is doing worse than 70.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.06% over the past year.
Measured over the past years, IDP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.31% on average per year.
IDP shows a small growth in Revenue. In the last year, the Revenue has grown by 1.59%.
The Revenue has been decreasing by -7.62% on average over the past years.
EPS 1Y (TTM)3.06%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%-17.71%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%6.13%
3.2 Future
Based on estimates for the next years, IDP will show a small growth in Earnings Per Share. The EPS will grow by 1.48% on average per year.
Based on estimates for the next years, IDP will show a decrease in Revenue. The Revenue will decrease by -0.48% on average per year.
EPS Next Y-7.32%
EPS Next 2Y-2.24%
EPS Next 3Y0.31%
EPS Next 5Y1.48%
Revenue Next Year-3.8%
Revenue Next 2Y-2.86%
Revenue Next 3Y-1.51%
Revenue Next 5Y-0.48%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
IDP is valuated reasonably with a Price/Earnings ratio of 8.37.
Based on the Price/Earnings ratio, IDP is valued cheaper than 93.85% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. IDP is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 8.42 indicates a reasonable valuation of IDP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IDP indicates a rather cheap valuation: IDP is cheaper than 98.46% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, IDP is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.37 | ||
| Fwd PE | 8.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IDP is valued cheaper than 90.77% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IDP is valued cheaply inside the industry as 93.85% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.46 | ||
| EV/EBITDA | 7.04 |
4.3 Compensation for Growth
The decent profitability rating of IDP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.24%
EPS Next 3Y0.31%
5. Dividend
5.1 Amount
No dividends for IDP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:IDP (7/4/2025, 7:00:00 PM)
112.45
-0.3 (-0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners92.86%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap16.48B
Analysts73.02
Price Target151.57 (34.79%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.97%
Min EPS beat(2)0.67%
Max EPS beat(2)17.28%
EPS beat(4)4
Avg EPS beat(4)13.01%
Min EPS beat(4)0.67%
Max EPS beat(4)28.61%
EPS beat(8)8
Avg EPS beat(8)8.78%
EPS beat(12)12
Avg EPS beat(12)10.47%
EPS beat(16)14
Avg EPS beat(16)9.94%
Revenue beat(2)2
Avg Revenue beat(2)3.39%
Min Revenue beat(2)0.11%
Max Revenue beat(2)6.67%
Revenue beat(4)3
Avg Revenue beat(4)1.89%
Min Revenue beat(4)-0.68%
Max Revenue beat(4)6.67%
Revenue beat(8)5
Avg Revenue beat(8)0.61%
Revenue beat(12)8
Avg Revenue beat(12)1.03%
Revenue beat(16)11
Avg Revenue beat(16)1.28%
PT rev (1m)-2.24%
PT rev (3m)-16.84%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-0.01%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-5.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.37 | ||
| Fwd PE | 8.42 | ||
| P/S | 1.98 | ||
| P/FCF | 8.46 | ||
| P/OCF | 7.52 | ||
| P/B | 1.14 | ||
| P/tB | 21.17 | ||
| EV/EBITDA | 7.04 |
EPS(TTM)13.43
EY11.94%
EPS(NY)13.36
Fwd EY11.88%
FCF(TTM)13.3
FCFY11.82%
OCF(TTM)14.95
OCFY13.3%
SpS56.86
BVpS98.35
TBVpS5.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 8.71% | ||
| ROCE | 11.36% | ||
| ROIC | 9.95% | ||
| ROICexc | 11.23% | ||
| ROICexgc | 55.5% | ||
| OM | 26.3% | ||
| PM (TTM) | 15.07% | ||
| GM | 75.58% | ||
| FCFM | 23.39% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
ROICexc(3y)12.43%
ROICexc(5y)16.11%
ROICexgc(3y)38.35%
ROICexgc(5y)40.12%
ROCE(3y)12.07%
ROCE(5y)15.58%
ROICexcg growth 3Y14.15%
ROICexcg growth 5Y-5.35%
ROICexc growth 3Y-15.93%
ROICexc growth 5Y-20.8%
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
F-Score6
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.74 | ||
| Debt/EBITDA | 1.38 | ||
| Cap/Depr | 40.34% | ||
| Cap/Sales | 2.91% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 78.44% | ||
| Profit Quality | 155.18% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 2.78 |
F-Score6
WACC9.13%
ROIC/WACC1.09
Cap/Depr(3y)54.43%
Cap/Depr(5y)68.89%
Cap/Sales(3y)3.09%
Cap/Sales(5y)3.21%
Profit Quality(3y)99.34%
Profit Quality(5y)120.98%
High Growth Momentum
Growth
EPS 1Y (TTM)3.06%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%-17.71%
EPS Next Y-7.32%
EPS Next 2Y-2.24%
EPS Next 3Y0.31%
EPS Next 5Y1.48%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%6.13%
Revenue Next Year-3.8%
Revenue Next 2Y-2.86%
Revenue Next 3Y-1.51%
Revenue Next 5Y-0.48%
EBIT growth 1Y21.69%
EBIT growth 3Y-8.8%
EBIT growth 5Y-18.9%
EBIT Next Year9.62%
EBIT Next 3Y4.45%
EBIT Next 5Y5.34%
FCF growth 1Y61.56%
FCF growth 3Y-9.06%
FCF growth 5Y-17.06%
OCF growth 1Y53.87%
OCF growth 3Y-7.56%
OCF growth 5Y-16.49%